AI MARKET SCANNING

$NOVO-B.CO

🔒 Europe

Novo Nordisk B A/S

📅 Next Catalyst: Nov 04, 2026 (🌙 Close) 🏛️ NASDAQ COPENHAGEN 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP -0.74%
MAX GAP RECORD -17.89%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $NOVO-B.CO
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 04, 2026 Earnings Release 2026-11-04 (AFTER CLOSE (16:00)) 🔮 UPCOMING 🔒
Aug 04, 2026 Earnings Release 2026-08-04 (AFTER CLOSE)
-3.12%
May 06, 2026 Earnings Release 2026-05-06 (BEFORE OPEN)
+4.93%
Feb 03, 2026 Earnings Release 2026-02-03 (AFTER CLOSE)
-17.89%
Nov 05, 2025 Earnings Release 2025-11-05 (BEFORE OPEN)
-3.78%
Aug 06, 2025 Earnings Release 2025-08-06 (BEFORE OPEN)
+1.34%
May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN)
-0.01%
Feb 05, 2025 Earnings Release 2025-02-05 (BEFORE OPEN)
+6.31%

VOLATILITY & GAP BIAS

AVG GAP MOVE 4.4%
Bullish Gaps (8)
Bearish Gaps (5)
Neutral / Flat (2)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $NOVO-B.CO

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-23 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1017m +5.21%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗